Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet.
The historical rank and industry rank for Azenta's Order Backlog for Technology (USD Mil) or its related term are showing as below:
FRA:BA3's Order Backlog for Technology (USD Mil) is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: * Ranked among companies with meaningful Order Backlog for Technology (USD Mil) only.
Azenta (FRA:BA3) Order Backlog for Technology (USD Mil) Explanation
The term backlog refers to a buildup of work that has not yet been completed by the company. The presence of a backlog can have positive or negative implications. For example, a rising backlog of product orders might indicate rising sales. On the other hand, companies generally want to avoid having a backlog as it could cause (or be a result of) increasing inefficiency in the production process. Likewise, a falling backlog might be a sign of lagging demand but could also be a result of improving production efficiency. Naturally, unexpected backlogs can compromise forecasts and production schedules.
Azenta Order Backlog for Technology (USD Mil) Related Terms
Azenta Order Backlog for Technology (USD Mil) Historical Data
* Premium members only.
The historical data trend for Azenta's Order Backlog for Technology (USD Mil) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azenta Order Backlog for Technology (USD Mil) Chart
What does a Order Backlog for Technology (USD Mil) of 0.00 mean?
Azenta (FRA:BA3) has a Order Backlog for Technology (USD Mil) of 0.00 as of . 20. Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet. View historical data on Azenta and its competitors.
Is Azenta's Order Backlog for Technology (USD Mil) too high?
Azenta's current Order Backlog for Technology (USD Mil) is 0.00. Overall, Azenta has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Order Backlog for Technology (USD Mil) compare to KMTS and STAA?
Azenta's Order Backlog for Technology (USD Mil) of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Order Backlog for Technology (USD Mil) for a Medical Devices & Instruments company?
A good Order Backlog for Technology (USD Mil) depends on the Medical Devices & Instruments industry context. However, Order Backlog for Technology (USD Mil) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Order Backlog for Technology (USD Mil) mean?
A high Order Backlog for Technology (USD Mil) can signal that a stock is expensive relative to its fundamentals. Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet. View historical data on Azenta and its competitors. Azenta's current Order Backlog for Technology (USD Mil) is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (FRA:BA3) is currently considered Significantly Undervalued. The stock's GF Value™ is €45.14, compared to a current price of €28.40 — trading 37.1% below its estimated fair value. The current Order Backlog for Technology (USD Mil) is 0.00. Azenta's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Order Backlog for Technology (USD Mil) calculated?
Order Backlog for Technology (USD Mil) is calculated from a company's financial statements. For Azenta (FRA:BA3), the current Order Backlog for Technology (USD Mil) is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azenta (FRA:BA3) Overvalued in 2026?
Based on GuruFocus' analysis, Azenta stock appears to be undervalued.
The current stock price of €28.40 is trading 37.1% below its estimated GF Value™ of €45.14.
GuruFocus considers Azenta to be Significantly Undervalued.
Key valuation signals for FRA:BA3:
Order Backlog for Technology (USD Mil): 0.00
GF Value™: €45.14 vs. price of €28.40 (37.1% below fair value)
No single metric tells the full story. See the FRA:BA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
78GF Score
Get the complete analysis for FRA:BA3
Order Backlog for Technology (USD Mil) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BA3 has been successfully added to your 
